• Amyloid-beta PET and CSF in an autopsy-confirmed cohortReimand, Juhan; Boon, Baayla D.C.; Collij, Lyduine E.; Teunissen, Charlotte E.; Rozemuller, Annemieke J.M.; Van Berckel, Bart N.M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeAnnals of clinical and translational neurology2020 / p. 2150−2160 https://doi.org/10.1002/acn3.51195 https://www.scopus.com/sourceid/21100823147 https://www.scopus.com/record/display.uri?eid=2-s2.0-85092711232&origin=inward&txGid=632d5a82f14ec02d45a449c9de416844 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=ANN%20CLIN%20TRANSL%20NEUR&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000579558600001
  • Association of amyloid-β CSF/PET discordance and tau load 5 years laterReimand, Juhan; Collij, Lyduine E.; Scheltens, PhilipNeurology2020 / p. e2648-e2657 : ill https://doi.org/10.1212/WNL.0000000000010739 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963352/ https://www.scopus.com/sourceid/17952 https://www.scopus.com/record/display.uri?eid=2-s2.0-85095972597&origin=inward&txGid=a40a5a71bfb6be7826b3779793b5ac7d https://jcr.clarivate.com/jcr-jp/journal-profile?journal=NEUROLOGY&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000619282800005
  • Discordance between amyloid-β PET and CSF biomarkers : clinical and pathophysiological consequences = Amüloid-β staatuse vastuolu PET-uuringul ning liikvorianalüüsil : kliiniline ja patofüsioloogiline tähendusReimand, Juhan2021 https://doi.org/10.23658/taltech.15/2021 https://www.ester.ee/record=b5431268*est https://digikogu.taltech.ee/et/Item/d14a365f-fbfc-4595-923e-473262485fe2
  • Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's diseaseVisser, Denise; Wolters, Emma E.; Verfaillie, Sander C.J.; Coomans, Emma M.; Timmers, Tessa; Tuncel, Hayel; Reimand, Juhan; Boellaard, Ronald; Windhorst, Albert D.; Scheltens, Philip; Scheltens, PhilipEuropean journal of nuclear medicine and molecular imaging2020 / p. 3165–3175 https://doi.org/10.1007/s00259-020-04831-w
  • Why is amyloid-β PET requested after performing CSF biomarkers?Reimand, Juhan; Groot, Colin; Teunissen, Charlotte E.; Windhorst, Albert D.; Boellaard, Ronald; Barkhof, Frederike; Nazarenko, Sergei; van der Flier, Wiesje M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeJournal of Alzheimer's disease2020 / p. 559-569 https://doi.org/10.3233/JAD-190836 https://www.scopus.com/sourceid/16246 https://www.scopus.com/record/display.uri?eid=2-s2.0-85078507057&origin=inward&txGid=00d41882032da9684bcf6453fabe39df https://jcr.clarivate.com/jcr-jp/journal-profile?journal=J%20ALZHEIMERS%20DIS&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000512318900012
  • Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extentCollij, Lyduine E.; Salvado, Gemma; Shekari, Mahnaz; Lopes Alves, Isadora; Reimand, Juhan; Wink, Alle Meije; Zwan, Marissa; Ninerola-Baizan, Aida; Perissinotti, Andres; Scheltens, PhilipEuropean journal of nuclear medicine and molecular imaging2021 / p. 2169–2182 https://doi.org/10.1007/s00259-020-05174-2 https://www.scopus.com/sourceid/16676 https://www.scopus.com/record/display.uri?eid=2-s2.0-85101270143&origin=inward&txGid=77bbe2f035ba87e17f1b5c0a573ca5ea https://jcr.clarivate.com/jcr-jp/journal-profile?journal=EUR%20J%20NUCL%20MED%20MOL%20I&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000620107500001